- Amended Statement of Ownership (SC 13G/A)
February 08 2011 - 3:00PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G
Under
the Securities Exchange Act of 1934
(Amendment No.
2
)*
Obagi Medical Products, Inc.
(Name
of Issuer)
Common Stock, $0.001 par value per share
(Title of Class of Securities)
67423R108
January 01, 2011
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
o
Rule
13d-1(b)
o
Rule
13d-1(c)
x
Rule
13d-1(d)
*
The remainder of this cover page shall be filled out for a reporting person’s
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The
information required in the remainder of this cover page shall not be deemed to
be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
|
|
|
|
|
|
1
|
|
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
|
|
STONINGTON CAPITAL APPRECIATION 1994 FUND L P
13764929
|
|
|
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE
INSTRUCTIONS)
|
|
(a)
o
|
|
(b)
o
|
|
|
|
3
|
|
SEC USE ONLY
|
|
|
|
|
|
|
|
4
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
Delaware
|
|
|
|
|
NUMBER OF SHARES
BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
|
5
|
|
SOLE VOTING POWER
|
|
|
|
0(1)
|
|
|
|
6
|
|
SHARED VOTING POWER
|
|
|
|
0
|
|
|
|
7
|
|
SOLE DISPOSITIVE POWER
|
|
|
|
0(1)
|
|
|
|
8
|
|
SHARED DISPOSITIVE POWER
|
|
|
|
0
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
|
|
|
|
0(1)
|
|
|
|
10
|
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
|
o
|
|
|
|
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
|
0%
|
|
|
|
12
|
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
|
PN
|
|
|
FOOTNOTES
|
|
|
|
(1) Reflects the sale of (a) 2,033,617 shares of the common stock of Obagi Medical Products, Inc. (the "Company") in November 2010 pursuant to a registration statement on Form S-1 that was filed with the Securities and Exchange Commission (the "SEC") on October 26, 2010 and declared effective by the SEC on November 15, 2010, and (b) 2,688,668 shares of the Company's common stock to the Company in accordance with the terms of a Stock Purchase Agreement, dated as of November 15, 2010, by and among the Company the Stonington Capital Appreciation 1994 Fund, L.P. and the other selling stockholder signatory thereto.
|
|
|
|
|
|
|
1
|
|
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
|
|
Stonington Partners, L.P.
|
|
|
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE
INSTRUCTIONS)
|
|
(a)
o
|
|
(b)
o
|
|
|
|
3
|
|
SEC USE ONLY
|
|
|
|
|
|
|
|
4
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
Delaware
|
|
|
|
|
NUMBER OF SHARES
BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
|
5
|
|
SOLE VOTING POWER
|
|
|
|
0(1)
|
|
|
|
6
|
|
SHARED VOTING POWER
|
|
|
|
0
|
|
|
|
7
|
|
SOLE DISPOSITIVE POWER
|
|
|
|
0(1)
|
|
|
|
8
|
|
SHARED DISPOSITIVE POWER
|
|
|
|
0
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
|
|
|
|
0(1)
|
|
|
|
10
|
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
|
o
|
|
|
|
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
|
0%
|
|
|
|
12
|
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
|
PN
|
|
|
FOOTNOTES
|
|
|
|
(1) Reflects the sale of (a) 2,033,617 shares of the common stock of Obagi Medical Products, Inc. (the "Company") in November 2010 pursuant to a registration statement on Form S-1 that was filed with the Securities and Exchange Commission (the "SEC") on October 26, 2010 and declared effective by the SEC on November 15, 2010, and (b) 2,688,668 shares of the Company's common stock to the Company in accordance with the terms of a Stock Purchase Agreement, dated as of November 15, 2010, by and among the Company the Stonington Capital Appreciation 1994 Fund, L.P. and the other selling stockholder signatory thereto.
|
|
|
|
|
|
|
1
|
|
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
|
|
Stonington Parters, Inc. II
|
|
|
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE
INSTRUCTIONS)
|
|
(a)
o
|
|
(b)
o
|
|
|
|
3
|
|
SEC USE ONLY
|
|
|
|
|
|
|
|
4
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
Delaware
|
|
|
|
|
NUMBER OF SHARES
BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
|
5
|
|
SOLE VOTING POWER
|
|
|
|
0(1)
|
|
|
|
6
|
|
SHARED VOTING POWER
|
|
|
|
0
|
|
|
|
7
|
|
SOLE DISPOSITIVE POWER
|
|
|
|
0(1)
|
|
|
|
8
|
|
SHARED DISPOSITIVE POWER
|
|
|
|
0
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
|
|
|
|
0(1)
|
|
|
|
10
|
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
|
o
|
|
|
|
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
|
0%
|
|
|
|
12
|
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
|
CO
|
|
|
FOOTNOTES
|
|
|
|
(1) Reflects the sale of (a) 2,033,617 shares of the common stock of Obagi Medical Products, Inc. (the "Company") in November 2010 pursuant to a registration statement on Form S-1 that was filed with the Securities and Exchange Commission (the "SEC") on October 26, 2010 and declared effective by the SEC on November 15, 2010, and (b) 2,688,668 shares of the Company's common stock to the Company in accordance with the terms of a Stock Purchase Agreement, dated as of November 15, 2010, by and among the Company the Stonington Capital Appreciation 1994 Fund, L.P. and the other selling stockholder signatory thereto.
|
|
|
|
|
|
|
1
|
|
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
|
|
Stonington Partners, Inc.
|
|
|
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE
INSTRUCTIONS)
|
|
(a)
o
|
|
(b)
o
|
|
|
|
3
|
|
SEC USE ONLY
|
|
|
|
|
|
|
|
4
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
Delaware
|
|
|
|
|
NUMBER OF SHARES
BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
|
5
|
|
SOLE VOTING POWER
|
|
|
|
0(1)
|
|
|
|
6
|
|
SHARED VOTING POWER
|
|
|
|
0
|
|
|
|
7
|
|
SOLE DISPOSITIVE POWER
|
|
|
|
0(1)
|
|
|
|
8
|
|
SHARED DISPOSITIVE POWER
|
|
|
|
0
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
|
|
|
|
0(1)
|
|
|
|
10
|
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
|
o
|
|
|
|
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
|
0%
|
|
|
|
12
|
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
|
CO
|
|
|
FOOTNOTES
|
|
|
|
(1) Reflects the sale of (a) 2,033,617 shares of the common stock of Obagi Medical Products, Inc. (the "Company") in November 2010 pursuant to a registration statement on Form S-1 that was filed with the Securities and Exchange Commission (the "SEC") on October 26, 2010 and declared effective by the SEC on November 15, 2010, and (b) 2,688,668 shares of the Company's common stock to the Company in accordance with the terms of a Stock Purchase Agreement, dated as of November 15, 2010, by and among the Company the Stonington Capital Appreciation 1994 Fund, L.P. and the other selling stockholder signatory thereto.
|
Item
1.
|
|
Obagi Medical Products, Inc.
|
|
(b)
|
Address
of Issuer’s Principal Executive Offices
|
|
|
3760 Kilroy Airport Way
Suite 500
Long Beach, CA 90806
|
Item
2.
|
(a)
|
Name
of Person Filing
|
|
|
This statement is filed jointly on behalf of the persons indentified below. In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), each person filing this statement acknowledges that it is responsible for the completeness and accuracy of the information concerning that person but is not responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate. The persons filing this Amendment No. 2 to the Schedule 13G (the "Schedule 13G") are:
i. Stonington Capital Appreciation 1994 Fund, L.P. (the "Stonington Fund")
ii. Stonington Partners, L.P. ("SP")
iii. Stonington Partners, Inc. II ("SP II")
iv. Stonington Partners, Inc. ("Stonington")
|
|
(b)
|
Address
of Principal Business Office or, if none, Residence
|
|
|
The address of the principal business office of all filing persons identified in this Schedule 13G is: c/o Stonington Partners, Inc., 600 Madison Avenue, 16th Floor, New York, New York 10022.
|
|
(d)
|
Title
of Class of Securities
|
|
|
Common Stock, $0.001 par value per share (the "Common Stock")
|
Item
3.
|
If
this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c),
check whether the person filing is a:
|
|
(a)
|
o
|
Broker
or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
|
(b)
|
o
|
Bank
as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
|
|
(c)
|
o
|
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
|
|
(d)
|
o
|
Investment
company registered under section 8 of the Investment Company Act of 1940 (15
U.S.C 80a-8).
|
|
(e)
|
o
|
An
investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
|
(f)
|
o
|
An
employee benefit plan or endowment fund in accordance with
§240.13d-1(b)(1)(ii)(F);
|
|
(g)
|
o
|
A
parent holding company or control person in accordance with §
240.13d-1(b)(1)(ii)(G);
|
|
(h)
|
o
|
A
savings associations as defined in Section 3(b) of the Federal Deposit
Insurance Act (12 U.S.C. 1813);
|
|
(i)
|
o
|
A
church plan that is excluded from the definition of an investment company under
section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
|
(j)
|
o
|
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J).
|
|
(k)
|
o
|
A group, in accordance with § 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify
the type of institution:
|
Provide
the following information regarding the aggregate number and percentage of the
class of securities of the issuer identified in Item 1.
|
(a)
|
Amount beneficially owned:
0
|
|
(c)
|
Number
of shares as to which the person has:
|
|
(i)
|
Sole power to vote or to direct the vote:
0
|
|
(ii)
|
Shared power to vote or to direct the vote:
0
|
|
(iii)
|
Sole power to dispose or to direct the disposition of:
0
|
|
(iv)
|
Shared power to dispose or to direct the disposition of:
0
|
Item
5.
|
Ownership
of Five Percent or Less of a Class
|
If
this statement is being filed to report the fact that as of the date hereof the
reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following
x
.
Item
6.
|
Ownership
of More than Five Percent on Behalf of Another Person.
|
Not applicable.
Item
7.
|
Identification
and Classification of the Subsidiary Which Acquired the Security Being Reported
on By the Parent Holding Company
|
Item
8.
|
Identification
and Classification of Members of the Group
|
Item
9.
|
Notice
of Dissolution of Group
|
Item
10.
|
Certification
|
|
|
|
Not applicable.
|
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement is true, complete and correct.
|
Stonington Capital Appreciation 1994 Fund, L.P.
|
|
|
|
|
|
Date:
February 04, 2010
|
By:
|
/s/
John A. Bartholdson
|
|
|
|
Name: John A. Bartholdson
|
|
|
|
Title:
Partner of Stonington Partners, L.P., its general partner, as Partner of Stonington Partners, Inc. II, its general partner
|
|
|
|
|
|
|
Stonington Partners, L.P.
|
|
|
|
|
|
Date:
February 04, 2010
|
By:
|
/s/
John A. Bartholdson
|
|
|
|
Name: John A. Bartholdson
|
|
|
|
Title:
Partner of Stonington Partners, Inc. II, its general partner
|
|
|
|
|
|
|
Stonington Partners, Inc. II
|
|
|
|
|
|
Date:
February 04, 2010
|
By:
|
/s/
John A. Bartholdson
|
|
|
|
Name: John A. Bartholdson
|
|
|
|
Title:
Partner
|
|
|
|
|
|
|
Stonington Partners, Inc.
|
|
|
|
|
|
Date:
February 04, 2010
|
By:
|
/s/
John A Bartholdson
|
|
|
|
Name: John A Bartholdson
|
|
|
|
Title:
Partner
|
|
|
|
|
|
Attention:
|
Intentional
misstatements or omissions of fact constitute Federal criminal violations (See
18 U.S.C. 1001)
|
Obagi Medical Products, Inc. (MM) (NASDAQ:OMPI)
Historical Stock Chart
From Sep 2024 to Oct 2024
Obagi Medical Products, Inc. (MM) (NASDAQ:OMPI)
Historical Stock Chart
From Oct 2023 to Oct 2024